We conclude that the bi-transgenic mice, which show increased DUX4-FL expression correlating with the degree of TMX treatment, resemble FSHD patient muscle biopsies, which show increased expression of known DUX4-FL target genes compared with control biopsies [26]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.